chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt c/o LD pain started on 9/18/01 after vaccine. Pt has had temperature, soreness and swelling to LD since 9/18/01 and has been taking Tylenol but ineffective. this sx continue from 9/18/01 to now.
pt had palpitations ,chest pain ,swelling and pain  from side on plank from armpit on both vacccine site ,dr suspected from vaccine mostly shingles
still got the flu/Worst case of it I ever had; Initial information received on 01-Oct-2023 regarding an unsolicited valid Social Media non-serious case received from a Patient.  This case involves an unknown age and unknown gender patient who reported still got the flu/worst case of it i ever had after receiving vaccine Influenza Vaccine.  The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer (lot number, strength, expiry date, dose and form not reported) via unknown route in unknown administration site as Prophylactic vaccination (immunization).  On an unknown date the patient reported still got the flu/worst case of it i ever had (influenza) (unknown latency) following the administration of Influenza Vaccine.  It was reported "Dude...I got the flu shot last year and my wife and I both still got the flu. My wife was hospitalized and I should have been."  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Pt vaccinated with DTP/HIB twenty minutes after given vaccine became limp/white/no neck tone. Symptoms reversed after 10 min by the time pt returned to office was sitting up/color improved.
HEADACHE; This spontaneous report received from a consumer concerned a 63 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included occasional sinus headache on and off. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. Concomitant medications included prednisolone. On 12-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: guaifenesin/paracetamol/phenylephrine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
Initial information received on 30-Apr-2019 regarding an unsolicited valid serious case received from other health professional. This case involves male patient who died after a reaction to horse serum in a tetanus vaccine, while he received vaccine TETANUS TOXOID. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect TETANUS TOXOID produced by unknown manufacturer lot number not reported via unknown route in unknown administration site. On an unknown date, patient died after a reaction to horse serum in a tetanus vaccine following the administration of TETANUS TOXOID. This event was leading to death. (Other relevant tests included no lab data.) Final diagnosis was (fatal) patient died after a reaction to horse serum in a tetanus vaccine. It was not reported if the patient received a corrective treatment. The outcome is reported as Fatal. It is unknown if an autopsy was done. The cause of death was reported as Allergic reaction to drug excipient. Information on the batch number was requested. Documents held by sender: none. Sender's Comments: This case concerns a male patient of an unknown age who died after a reaction to horse serum in a tetanus vaccine after vaccination with TETANUS TOXOID produced by unknown manufacturer. No conclusion can be made at this point, as no autopsy results are available. This case lacks important data such as past medical history of the patient and of his family, medical circumstances in the previous days and autopsy findings, to assess it.. Reported Cause(s) of Death: reaction to horse serum in a tetanus vaccine.
Pt. received 4 immunization on 1/12/11. Mom detected swelling and a knot under the skin at the immunization site on (L)AT. Area was tender. Mom took child to ED on 1/19/11. Culture was not done. Diagnosed at ED sterile abscess secondary vaccines. No medications given. Mom states warm compress advised. 1/21/11 Mom called ED would like reevaluation. Seen 1/21/11 Dx abscess (L) thigh. Cultured, result MRSA on 1/24/11. Appt for 1/25/11 to reevaluate.
PATIENT RECEIVED PFIZER MONOVALENT VACCINE AS BOOSTER INSTEAD OF PFIZER BIVALENT VACCINE
Pt. describes a "bump" 1/2 inch the next day which caused itching & was raised. A red rash about 2 " also occurred. The area is still sore to touch 2 days later. Pt used 50mg BENADRYL & had no temperature.
Focal motor left eye tic - started same day after flu shot. Large local reaction - lasted few day. Note known past allergy to eggs but now eats no symptoms.
pt recvd vax 20JUN94 & w/in 12 hrs p/vax exp a febrile sz; seen in ER-fever 105; treated w/tepid bath & APAP; No anticonvulsants administered; 22JUN low grade fever; pt improving; previously recvd 3 doses of DTP w/no adverse event;
Information has been received from a physician concerning a 4 yr old male pt who on 30-MAR-2000 was vaccinated with a dose of measles virus vaccine live and mumps virus vaccine live and rubella virus vaccine live (second generation) (lot # 1714J). Concomitant vaccinations that same day included poliovirus vaccine (IPOL) (lot #P1231) and aluminum potassium sulfate and diphtheria toxoid and pertussis vaccine and tetanus toxoid (Tripedia) (lot #00161CA). On 30-MAR-2000, the pt also had a Mantoux test (Tuber Sol) 5 TU in the forearm. The day following vaccination, the pt was not feeling himself and developed a red mark around the area of the shot. On an unspecified date the pt recovered. No further information is available.
high fever/High temperature; tested positive for COVID-19; tested positive for COVID-19; No taste or smell; No taste or smell; This is a spontaneous report from a contactable consumer via team and Pfizer-sponsored program. An 82-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 07Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. Medical history and concomitant medications were reported as none. On 05Mar2021, the patient tested positive for COVID-19 and has been hospitalized twice with a high fever, high temperature: 103.5. The patient has been in and out of the hospital. The reporter was asking, "Does he have to start over from scratch with the second vaccine dose since it has ben over 6 weeks from the first?" The patient also had no taste or smell on 05Mar2021. The patient was hospitalized from 05Mar2021 to 07Apr2021. The patient recovered from the events fever in Mar2021 and also recovered from the event COVID-19 on unspecified date. The outcome of no taste and smell was not recovered.  Information about lot/batch has been requested.
Immediately following the administration of the vaccine pt complained of blurry vision and dizziness. The pt was put into a supine position with her legs elevated while her vitals were taken. Pt's vitals were all normal with the exception of her blood pressure. It was 94/60, which was low compared to other BPs we have on file for this pt. Pt was given a snack and water while she recovered. The pt reported she had not eaten yet and is very afraid of needles and believed this contributed to the event. The pt never lost consciousness. The pt was monitored for 30 minutes and at around 12:30 PM the pt felt well and asked to leave.
Presented w/ malaise, body aches, HA, SOB X2-3 days. Covid +. Tx w/ Decadron, O2, Rocephin
Body aches; Flu like symptoms; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), INFLUENZA LIKE ILLNESS (Flu like symptoms) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (Body aches), INFLUENZA LIKE ILLNESS (Flu like symptoms) and HEADACHE (Headache). At the time of the report, PAIN (Body aches), INFLUENZA LIKE ILLNESS (Flu like symptoms) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no relevant concomitant medications was reported. No treatment information was provided   Reporter did not allow further contact
Pt stayed for 15 minute observation time and then went to the cafe to eat breakfast.  Once she got in her car about 45 minutes after, she noticed her lips were swelling.  Pt took 25 mg of Benadryl.  She continued to have to take it q4h on day of vaccine.  Over the next 2 days she started to cut back on the amount of Benadryl she was taking but lips were still swollen some.  She saw her PCP on 12/21/2020 and was told to continue Benadryl as needed and to take Pepcid 20 mg daily until better.
area about size of a tennis ball that was swollen very red & hot very sore for 3 days;flu vax recv in individual doses from wyeth w/ 5/8" needle;
developed Tinnitus; This case was reported by a physician via call center representative and described the occurrence of tinnitus in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number K9R97, expiry date unknown) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced tinnitus. On an unknown date, the outcome of the tinnitus was unknown.   It was unknown if the reporter considered the tinnitus to be related to Shingrix  Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix and developed Tinnitus.  The reporter consented to follow up. .
Severe loss of muscle strength Could not bend over to touch floor Pain or aching in almost all joints (8) Pain trying to enter or exiiit car    (10) Pain sitting in car for more than 25 miles  (9) Increase in Diabetic readings by 20-40 points at all reading times Pain in injection site (still Present at this date)  Restricts motion
Severe rash on both arms and back of thigh. Intese itchiness on entire body. Patient has neve had rashes before.
sick; fever; chills; body aches; chest pains; This is a spontaneous report received from a contactable reporter(s) (Consumer), Program ID: The reporter is the patient.  An adult female patient received BNT162b2, as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunization. The patient's relevant medical history included: "Chronic lung disease" (unspecified if ongoing); "chronic obstructive pulmonary disease" (unspecified if ongoing); "cystic fibrosis" (unspecified if ongoing); "Heart disease" (unspecified if ongoing); "congenital heart disease" (unspecified if ongoing); "congestive heart failure" (unspecified if ongoing); "coronary artery disease" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Thyroid" (unspecified if ongoing); "reflux" (unspecified if ongoing); "Heart failure due to mitral valve failure", start date: 07Feb2013 (unspecified if ongoing); "Heart failure due to mitral valve failure", start date: 07Feb2013 (unspecified if ongoing); "Mitral valve repair" (unspecified if ongoing); "Heart attack" (unspecified if ongoing); "Two stents placed in right coronary art." (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE oral taken for thyroid disorder, start date: 2010 (ongoing); OMEPRAZOLE oral taken for gastrooesophageal reflux disease, start date: 2013 (ongoing); CITIZEN oral taken for cardiac disorder, start date: 2016 (ongoing); ASPIRIN (E.C.) oral taken for cardiac disorder, start date: 2013 (ongoing). Vaccination history included: Bnt162b2 (DOSE 1, lot # not provided), for COVID-19 Immunization, reaction(s): "chest pain", "chills", "body aches", "fever", "right arm hurt ached immediately after shot". The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sick"; PYREXIA (non-serious), outcome "unknown", described as "fever"; CHILLS (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "body aches"; CHEST PAIN (non-serious), outcome "recovered", described as "chest pains". Additional information: It was stated that the patient got sick after every COVID shot. She was staying away from the mRNA kind. Within 24 hour, the patient had fever, chills, body aches and chest pains and the exact same thing happened after dose 2 and booster. The patient did not seek medical attention the chest pains lasted 2-3 days.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Linked Report(s): US-PFIZER INC-202300180440 same patient/drug, different dose number/event; US-PFIZER INC-PV202300029860 same patient/drug, different dose number/event.
Shortness of breath at 8pm. Chest felt heavy like it was pulling down on me.
Patient received 2nd dose of moderna on 4/7/22. Said today (~week later) she started developing a bright red rash around most parts of her body - arm,legs, trunk, face. This rash was warm to the touch. Patient just started benadryl to see if that will help. Is going to monitor and possibly call doctor if continues or gets worse.
I got my shot 8 days ago and starting today I noticed I am developing hives, the injection area is warm. Red and itching badly. I am also developing hives
02/25/2021- Had redness to injection site, swollen and warm to touch.  02/26/2021 (evening) Had itching and a rash all over her body. 02/27/2021- Rash turned into blisters over her body that morning.  Around 2 pm she felt like it was hard to breath and swallow.  Had been taking Benadryl every 4 hours since 02/26/2021.  Today the rash and blisters are better. States breathing is better but it is still hard to take a deep breath.  Her scalp is still sore.  Has a phone call into PCP and awaiting a phone call.
Information has been received from a physician concerning a 59 year old female with hypertension, hypercholesterolaemia, and allergies to penicillin and aspirin who on 27-NOV-2007 was vaccinated SC with a single dose of Zostavax (Oka/Merck).  Concomitant therapy included LIPITOR and AVAPRO.  On 05-DEC-2007 the patient experienced onset of a painful, pruritic rash on her left mid-thoracic region which extended to the left mid-back.  The patient was examined in the office on 07-DEC-2007 and was diagnosed with suspected herpes zoster.  There were no lab studies performed.  At the time of the report the patient had not recovered.  There was no product quality complaint involved.  No further information was provided.  Additional information has been requested.
Pt reports a bitter smell/taste beginning the night of vaccination. This has led to nausea and trouble eating/sleeping. Pt reported reaction was continuing 10 days post vaccination. Has tried mouthwash with no relief. Suggested sugar-free candies and follow-up with primary Md.
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. Pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with improperly stored ROTATEQ, lot # K016263, expiry date 26-JUN-2015, (dose, frequency and route of administration not reported). No adverse symptoms reported. No product quality complaint (PQC) was involved. No further information provided. This is one of three reports received from the same reporter. Additional information has been requested.
2nd Covid-19 Pfizer vaccine received on August 27th, 2021 for my 15 year old daughter.  8 days later, on September 4th 2021, my daughter started vomiting without stopping for 24 hours straight.  Went to the nearby emergency room and was admitted to ER.  Transported from one hospital to another after administering IVs,  Xray, blood tests, and urine tests.  Transferred by ambulance to Hospital  to be seen by a pediatrician at another hospital.  Vomiting continued.  Ultrasound test revealed inflamed appendix, and emergency appendectomy was performed on September 5th 2021.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 42 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Dec2022) Positive, notes: Positive text and symptoms 2 days after completing Paxlovid medication. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: COVID-19 rebound. Positive text and symptoms 2 days after completing Paxlovid medication. COVID 19 Treatment started on 02Dec2022 and stop date was 07Dec2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a nurse via call center representative and described the occurrence of vomiting in a 6-month-old female patient who received ROTARIX (batch number A41CB543A, expiry date 24th February 2017). Co-suspect products included ROTATEQ. Previously administered products included ROTATEQ (1st dose received on 14th December 2015). On 20th April 2016, the patient received ROTARIX 1 ml. On an unknown date, the patient received the 2nd dose of ROTATEQ. On 20th April 2016, 1 hr after receiving ROTARIX, the patient experienced vomiting, underdose and interchange of vaccine products. On an unknown date, the outcome of the vomiting, underdose and interchange of vaccine products were unknown. It was unknown if the reporter considered the vomiting to be related to ROTARIX. Additional details provided were as follows: This case was identified as a duplicate of case US2016056503. Case US2016056503 was deleted and all the future correspondence will be added in the present case which stands as case of record for this patient. On 14th December 2015, the patient received a dose of ROTATEQ vaccine. On 20th April 2016, the patient received a dose of ROTARIX, which led to an interchange of vaccine products. About an hour after receiving a dose of ROTARIX, the patient spitted out the dose. This led to an underdose. No further information was reported regarding the event.
was black in front of the eyes; feeling weak; Pulse around 15:50 instead of 15:70 as normal; fever; don't feel well; dizziness when standing up; circulatory disturbance; tired; A spontaneous report was received from a Consumer concerning himself, 78 Years old male patient who received second dose of Moderna's COVID-19 vaccine (mRNA-1273) and experienced, fever, Feeling unwell/ Malaise, dizziness when standing up, circulatory disturbance, was black in front of the eyes/ Eye disorder, feeling weak/ Asthenia, Pulse irregular.  The patient's medical history was not provided.   The relevant concomitant medications are amiodarone hydrochloride half a tablet a day, cholesterol against sugar.  On 03 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the upper arm for prophylaxis of COVID-19 infection.  On 02 Mar 2021, approximately one day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On 03 Mar 2021, with onset latency of two days, the patient experienced fever, did not feel well and felt dizzy on standing and had circulatory disturbance. Next day, the patient reported that it was black in front of his eyes. After checking his pulse, the patient called up emergency and was hospitalized. The patient was still feeling very weak and was still in care.  No Laboratory investigations were provided. No Treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  At the time of this report, the outcome of the events were unknown and for weakness was not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047206:case for first dose events.
11/19/04-Received phone call from patient stating she received a Flu and Pneumonia shot on 11/10/04.  On 11/11/04 she states she had reddness, pain and swelling in right arm and saw a doctor and was treated with SMZ-TMP DS.  On 11/15/04 patient went to her doctor who admitted patient to hospital. Patient was treated for cellulitis with blister 1cm. Patient was treated with IV Unasyn 1.5 grams now and every 6 hours Decadron.
Seven hours post injection, started to feel chills and achy-lasting all night. At 10:10 am today I took my temperature orally-99.9.
WHOLE ARM IS SWOLLEN AND PAIN RADIATING DOWN MY ARM AND UP OVER MY SHOULDER.  PAIN STARTED THE EVENING OF 14-OCT-2021 AND HAS INCREASED IN PAIN AND SWELLING THROUGHOUT THE DAY 15-OCT-2021. OTC MEDICATION HAS NOT LESSENED THE PAIN AND/OR SWELLING.
Confirmed Breakthrough Case   COVID-19 (Moderna) 1  02/03/2021 Moderna 011M20A   COVID-19 (Moderna) 2  03/03/2021 Moderna 010A21A   COVID-19 (Moderna) 3  12/16/2021 Moderna 005C21A   COVID-19 (Moderna) 4 05/11/2022 Moderna 004M21A
About a week after injection I developed a cold sore on my upper lip.   It lasted over 10 days before healing